MEGF0444A
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for MEGF0444A, covering 2016-08-26 to 2016-11-02. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease (NILE) [Phase 2]